CD274 and glioblastoma: PD-L1 is upregulated in GBM through the following mechanisms: (i) oncogenic signaling as a result of PTEN loss,15 (ii) paracrine signaling,16 and/or (iii) “adaptive immune resistance” whereby T-cell-secreted IFNγ induces PD-L1 expression on neighboring cells.51